28 COVID-19 Therapeutics and 11 Vaccines Approved for Clinical Trials in Korea

[Image source=Yonhap News]

[Asia Economy Reporter Jo In-kyung] The Ministry of Food and Drug Safety announced on the 28th that a total of 39 items have been approved for clinical trials so far, including 28 COVID-19 treatments and 11 vaccines.

Among the 28 COVID-19 treatments approved for clinical trials, 21 are domestically developed drugs. Of these, clinical trials for 14 items are currently underway, and 7 items have been completed.

There are 7 foreign-developed treatments, of which 3 are currently in the clinical trial phase and 4 have completed clinical trials.

Among the 11 COVID-19 vaccines, 10 are domestically developed and 1 is foreign-developed, all of which are currently undergoing clinical trials.

By platform, there are 5 recombinant vaccines, 3 DNA vaccines, 2 RNA vaccines, and 1 viral vector vaccine.

An official from the Ministry of Food and Drug Safety stated, "We are continuously monitoring the progress of clinical trials for COVID-19 treatments and vaccines and are doing our best to ensure safety management," adding, "We will continue to strive to ensure that clinical trials are conducted safely and promptly."